Study to Evaluate Effectiveness of Aranesp®

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

NCT07181135 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted

NCT03832114 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis

NCT03612856 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

NCT02894905 ·Status: COMPLETED ·Phase: PHASE1

PK Study of ACHN-490 Injection in Renally Impaired Subjects

NCT01462136 ·Status: COMPLETED ·Phase: PHASE1

CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

NCT03998163 ·Status: COMPLETED ·Phase: PHASE3

Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model

NCT05936021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

NCT01459250 ·Status: COMPLETED ·Phase: PHASE1

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

NCT04154670 ·Status: COMPLETED ·Phase: PHASE1

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

NCT01742585 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

NCT00863707 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

NCT06248567 ·Status: COMPLETED ·Phase: PHASE1

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

NCT01054261 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants

NCT04616677 ·Status: COMPLETED ·Phase: PHASE1

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis

NCT00704678 ·Status: COMPLETED ·Phase: PHASE2

Effect of Finerenone in IgA Nephropathy

NCT06580288 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

NCT00596518 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy

NCT01845688 ·Status: COMPLETED ·Phase: NA

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

NCT00805090 ·Status: COMPLETED ·Phase: PHASE1

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

NCT07187713 ·Status: RECRUITING ·Phase: PHASE4

Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects

NCT05948059 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

NCT01742611 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.

NCT03890770 ·Status: COMPLETED ·Phase: PHASE1

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

NCT00772382 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

NCT06573411 ·Status: RECRUITING ·Phase: PHASE4